BBBernadette Brady

Bernadette Brady

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bernadette Brady has a total of 160 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perspective Chapter: Reframing Pain Care for Cultural Diversity – Intersectional Perspectives on Assessment, Adaptation and Equity

    by Bernadette Brady, Robert Boland, Irena Veljanova

    Pain is not experienced, communicated, or treated in a cultural vacuum. This chapter reframes pain care for culturally and linguistically diverse (CALD) communities through an intersectionality lens, arguing that pain-related inequities emerge from the interplay of social identities and the structural organization of health systems. It synthesizes evidence showing that ethnoculturally diverse groups experience a differential burden of persistent pain and face barriers to accessing and benefiting from multidisciplinary care, including language discordance, mismatched expectations, and clinician bias. The chapter critically examines why Western-developed pain assessment approaches, particularly numeric scales and standardized questionnaires, may lack cultural validity in low-literacy and diverse populations, and outlines the limitations of translation alone. It then presents culturally responsive alternatives that explicitly elicit meaning, context, and personhood, including narrative-based interviewing and the Pictorial Representation of Illness and Self Measure (PRISM +), illustrated through a clinical vignette. Finally, the chapter reviews principles and frameworks for cultural adaptation of evidence-based pain interventions, contrasting content-driven and process-driven approaches, and summarizes emerging trial evidence in culturally tailored pain management. The chapter concludes with practical strategies for clinicians and services to advance equity, including culturally safe assessment, community co-design, and system-level accountability for equitable access, engagement, and outcomes.

  • Open Access

    Stakeholders’ Perspectives on the Development of the Early Pain Intervention After Knee Replacement Model of Care: A Qualitative Study

    by Mres Navneet Chadha Bphysio, Joshua R. Zadro BAppSc (Hons), FRACS(Ortho) Sam Adie PhD, FRACS(Ortho) Ian A. Harris PhD, Ilana N. Ackerman Bphysio (Hons), Deanne E. Jenkin, Blake F. Dear MClinPsych, Christopher G. Maher BAppSc (Phty), FRACP Rachelle Buchbinder PhD, Laurent Billot Mres, et al.

    Objective: Persistent pain affects around 20% of Australians after total knee replacement (TKR), yet no dedicated Australian model of care exists to address this unmet need. The Early Pain Intervention after Knee replacement (EPIK) model is being developed, informed by the effective and cost‐effective UK Support and Treatment After Replacement care pathway and extensive multistakeholder engagement. Before evaluating the EPIK model of care in a randomized controlled trial, it must be adapted for the Australian context. This qualitative study aimed to explore stakeholders’ perspectives to inform this adaptation. Methods: This qualitative descriptive study, guided by a subtle realist ontologic stance and a pragmatic epistemology, used semistructured interviews with key stakeholders across Australia. A preinterview screening questionnaire captured demographic, clinical, and professional characteristics which informed purposive sampling to ensure diverse views. Interviews were audio‐recorded, transcribed verbatim, and analyzed using inductive analysis. Results: Sixty‐one participants were interviewed (9 patients, 20 physiotherapists, 15 orthopedic surgeons, 14 general practitioners, 1 nurse, and 2 health fund managers) across all six states and the Australian Capital Territory, with 75% residing in metropolitan areas. We identified four key themes: (1) living with pain after TKR, (2) acceptability and value of EPIK, (3) defining the scope of the EPIK care coordinator, and (4) infrastructure and system‐level challenges. Conclusion: The EPIK model was well accepted by stakeholders as the first approach designed to improve care coordination for Australians with persistent pain after TKR, with potential to support a more efficient and patient‐centered health care system. These insights will inform the EPIK model, which will be tested in a registry‐nested randomized controlled trial.

  • Open Access

    Understanding Patient and Clinician Perspectives in the HITH4Hips Trial: A Qualitative Study

    by Jananee Myooran, Justine Naylor, Marie K. March, Danielle Ní Chróinín, Thuy Anh Bui, Nicholas Bednorz, Shu‐Hsuan Chen, Bernadette Brady

    Objectives: Early‐discharge models for hip fracture care are increasingly used to reduce hospital length of stay and healthcare burden, but stakeholder experiences remain underexplored. This study aimed to explore the experiences of patients, carers and healthcare providers (HCPs) involved in a multidisciplinary Hospital In The Home (HITH4Hips) program for low‐trauma hip fractures, and to identify factors influencing its implementation. Methods: Guided by the RE‐AIM QuEST (REach, Adoption, Implementation and Maintenance Qualitative Evaluation for Systematic Translation) framework, semi‐structured interviews were conducted with stakeholders involved in the HITH4Hips program at a metropolitan trauma hospital in Sydney, Australia. Interviews were transcribed verbatim and analysed using a rapid assessment approach with hybrid inductive–deductive coding. Themes were developed through interpretive analysis. Results: Nineteen interviews were completed, including 14 patients/carers (10 HITH4Hips participants; four usual care who declined HITH4Hips, mean age 75 years, 64% women, 86% from culturally and linguistically diverse background) and five HCPs. Four themes were developed: (1) Suitability for HITH: patients preferred home‐based recovery, whereas HCPs were more risk‐averse; (2) Perceptions of program effectiveness: patients prioritised emotional well‐being and functional progress, while HCPs emphasised measurable outcomes; (3) HCP mindset and orientation: role ambiguity and variable staff engagement limited program adoption; and (4) Realising program value: siloed communication and weak inpatient–community linkages hindered implementation. Conclusions: The HITH4Hips program was acceptable and has the potential to reduce healthcare system burden. Successful implementation will require tailored communication strategies and coordinated care pathways to align patient and provider priorities.

  • Open Access

    Who is waiting to see the surgeon? sociodemographic, clinical characteristics and previous osteoarthritis care of people with knee osteoarthritis referred to public hospitals in Victoria, Australia

    by Juanita Low, Danilo De Oliveira Silva, Allison M. Ezzat, Alison J. Gibbs, Bernadette Brady, Michelle M. Dowsey, Vincent Lengkong, Adrienne Forsyth, Clarice Y Tang, Ilana N. Ackerman, et al.

  • Open Access

    Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty

    by Jonathan Penm, Shania Liu, Sam Adie, Claire E Ashton-James, Kylie A Bailey, Bernadette Brady, Betty Chaar, Jenny Chen, Joseph Descallar, Klaudia Englezos, et al.

    Introduction: Despite limited evidence of efficacy, opioid analgesics are frequently used by patients for chronic pain while awaiting total hip or knee arthroplasty (THA or TKA). Preoperative use of opioids is problematic as it increases the likelihood of postoperative opioid-related adverse drug events and postoperative complications and is the strongest predictor of persistent opioid use post surgery. Opioid tapering prior to elective surgery has been proposed as a strategy for mitigating harms and improving postoperative outcomes. This protocol describes a randomised clinical trial, which aims to determine the effectiveness of a preoperative pharmacist-partnered opioid tapering programme compared with standard care for patients awaiting elective THA or TKA on postoperative outcomes including persistent opioid use. Method and analysis: Eligible participants must be aged ≥18 years; awaiting elective unilateral or bilateral THA or TKA; speak and read English; use prescription opioid analgesics at least 4 days a week and have access to internet or telephone. The participants will be excluded if they are undergoing a repeat surgery (same procedure within 6 months), are using opioids for cancer, palliative care or substance use disorder; have previously or are currently undergoing an opioid tapering programme or active medication review or have cognitive impairment. Enrolled participants will be randomised in a 1:1 ratio in permuted blocks of two and four to: (1) intervention or (2) standard care. A total of 314 participants will be recruited into the study. The intervention will include a pharmacist-partnered opioid tapering programme in which a pharmacist will work with participants to reduce their opioid dose over a 3-month period before surgery. Standard care will involve review by the hospital preadmission clinic multidisciplinary team to assess medical, physical and psychological health prior to surgery and education sessions for preoperative and postoperative care. The primary outcome assessed is persistent opioid use 3 months post surgery. The key secondary outcome is total Western Ontario and McMaster Universities Arthritis Index score. Data analysis will be performed using an estimand framework, with a generalised estimating equation model for the primary outcome from 1 day to 3 days presurgery to 3 months post surgery and a multilevel model for the main secondary outcome from baseline to 3 months after surgery. Cost-effectiveness and cost-utility analyses will be conducted to determine whether the intervention is cost-effective from the healthcare system perspective. Ethics and dissemination: Ethics approval for this study was granted by a Human Research Ethics Committee (approval number: 2023/ETH01042). Results will be disseminated in peer reviewed journals, at international scientific meetings as well as meetings with key stakeholders and via the media. Trial registration number: ACTRN12623000685617.

  • Open Access

    The minimal clinically important difference for the patient activation measure in a culturally and linguistically diverse cohort with chronic conditions

    by Robert Boland, Joseph Descallar, Justine M. Naylor, Gavin Williams, Bernadette Brady

    Purpose: To estimate the Minimally Clinically Important Difference (MCID) for the Patient Activation Measure (PAM) in a culturally diverse sample of people with chronic disease. Methods: This study was embedded in a larger cluster randomised trial exploring chronic disease management interventions in a culturally diverse sample of 254 adults. Patients were consecutively recruited across 16 outpatient clinics in Sydney, Australia and completed a range of outcomes related to the trial, including the Patient Activation Measure at recruitment and 6 months later. For the current study, the MCID for the PAM was estimated using two distribution methods and four anchor-based methods: mean change difference, and from the receiver operating characteristic curve, the Euclidean and Farra methods, and the Youden Index. A modified self-reported global impression of change, aligned to key elements of the PAM, was used as the external criterion and scores were dichotomised into ‘improved’ and ‘not improved.’ Therefore, the results are likely to overestimate the MCID. Results: 228 participants completed pre- and post-assessments; 51% in the improved group and 49% in the not improved group. Anchor-based methods produced MCIDs between 4 and 7.9, with a value of 4.7 from the preferred Youden method. Distribution-based methods produced MCIDs ranging from 0.26 (standardised effect size) to 5.88 PAM points. Conclusion: Different methods of calculating the PAM for MCID provided different results. Using the preferred Youden Index method, an MCID of 4.7 PAM points was identified as clinically meaningful in this culturally diverse chronic disease cohort. Wider estimates from other anchor-based methods (4.0 to 7.9) are reported to illustrate methodological variability. Trial registration: Study data were collected during a two-phase hybrid cluster randomised controlled trial, approved by the South Western Sydney Local Health District Human Research Ethics Committee (2021/ETH12279) and registered prospectively on the Australian and New Zealand Clinical Trials Registry (ACTRN12622000697785).

  • Open Access

    “It’s part of getting old”: ageing perceptions and cultural beliefs underpin hip recovery and refracture prevention experiences: a qualitative study

    by Bernadette Brady, Sacha Bossina, Amal Maximous, Seema Padmakumari Radhakrishnan, Danielle Ní Chróinín, Michelle Singh, Clarice Tang, Balwinder Sidhu, Carlos El-Haddad, Daraveasna Daing, et al.

    Background and Aims: Hip fractures are a leading cause of morbidity and mortality among older adults, with significant consequences for recovery and refracture risk. While recovery experiences have been explored and interventions established, limited understanding exists of how individual, social and cultural factors influence engagement with recovery and secondary prevention in multicultural systems. We explored these factors among culturally diverse older adults and caregivers following low trauma hip fracture. Methods: A qualitative study embedded within a prospective cohort at a metropolitan Australian trauma hospital. Participants included older adults with recent low-trauma hip fracture and their caregivers, purposively sampled for cultural diversity. Semi-structured interviews were conducted in English, Arabic, Assyrian or Vietnamese. Data were thematically analysed using a two-step inductive-deductive approach, mapping codes to Andersen’s Behavioural Model before theme development. Results: Twenty participants (mean age 74 years, 60% women, 75% culturally diverse) were interviewed. Three interconnected themes emerged: (i) ‘normalisation of pathological ageing’, shaping expectations and engagement with preventive care; (ii) ‘cultural orientations’ shaping motivations, expectations and family roles; and (iii) ‘care continuity,’ with refracture prevention clinics valued but access hampered by logistical and system barriers. These themes interacted across individual, social and health system levels to shape recovery trajectories and refracture prevention. Conclusions: Recovery and refracture prevention after hip fracture are strongly shaped by age-related beliefs, cultural context and care structures. By examining cross-cultural experiences in a multicultural setting, this study highlights the need for person-centred, culturally responsive and better-coordinated models to optimise engagement and outcomes in diverse ageing populations.


  • Open Access

    A Systematic Review of the Effectiveness of Rehabilitation Programmes or Strategies to Treat People With Persistent Knee Pain Following a Total Knee Replacement

    by Nathan Johns, Justine M. Naylor, Dean McKenzie, Bernadette Brady, Brinda Thirugnanam, John Olver

    Background: Persistent high levels of knee pain after a total knee replacement have been estimated to affect 5%–10% of people and this is related to dissatisfaction with surgery, reduced function and reduced quality of life. This systematic review aims to evaluate the effectiveness of rehabilitation programs or strategies to reduce persistent pain and improve function and quality of life in people following a total knee replacement.Methods: The systematic review was conducted following PRISMA guidelines with a search of relevant online databases up to 17 July 2024. The search criteria included English language randomised controlled trials of rehabilitation programs or strategies in any setting to treat people with persistent knee pain more than 3 months after a total knee replacement. Rehabilitation could include exercise, education, cognitive strategies and self‐management programs and excluded medication trials, procedural techniques and complementary therapies.Results: After removal of duplicates, there were 468 abstracts screened for eligibility with 23 remaining for full‐text screening and finally, one study meeting the eligibility criteria. This study's interventions were pain neuroscience education alone and pain neuroscience education plus neuromuscular exercise. There were no statistically significant between‐group differences for pain reduction or functional improvement.Conclusion: The evidence examining the value of rehabilitation programs or strategies for pain reduction and functional improvement in people with persistent pain following total knee replacement is deficient. Given the high number of people affected annually, further research concerning both prevention and management of persistent pain after knee replacement is warranted.


  • Open Access

    Structural racism and inequity in cancer clinical trial participation: time for solutions

    by Abhijit Pal, Rayan Saleh Moussa, Ben Smith, Bernadette Brady, Deme Karikios, Frances Boyle, Wei Chua

    In this issue of the Journal, Guadamuz et al. ( 1) report on the relationship between social determinants of health (SDOH) and cancer clinical trial participation among Black and Latinx patients in the Flatiron Health database, which includes data on more than 250 000 patients from 2011 to 2023. Unsurprisingly, they reaffirm substantial disparities in clinical trial participation. Black and Latinx patients are 40%-50% less likely to participate in clinical trials than White patients, despite clear US laws, such as the 1993 National Institutes of Health Revitalization Act ( 2) and laws mandating insurance coverage for trials. This study, however, provides quantifiable estimates of the contribution of different mediators to these disparities, which is a notable step forward in the trial participation literature. As shown in previous studies ( 3), it does not appear that patients from minoritized populations decline offers of trial participation—rather, they are not provided with the opportunity to participate because of where they reside or health-care professional biases. Similar to their previous research ( 4), the authors link trial data to American Community Survey and US Census Bureau data and relate area-level SDOH factors to the outcome of interest. This database linkage enables the authors to explore the disparity thoroughly through mediation analysis. They demonstrate that area-level SDOH, particularly measures of structural racism and practical obstacles, account for the majority of inequity in trial participation. Neighborhood racial and ethnic composition, a proxy for segregation, was considered the most substantial mediator and explained one-third of the inequities between Black, Latinx, and White patients. The authors point to site factors such as clinician bias and institutional racism and to sponsor factors such as their preference for partnering with well-resourced cancer care facilities, which tend not to serve minority populations. At the patient level, the authors ( 1) show that area-level vehicle ownership was an important mediator, highlighting a tangible opportunity to improve equity by providing transportation assistance. Limited proficiency in English was an important mediator of Latinx-White inequity and provides further evidence of the importance of providing reliable interpreter access and translated materials.


  • Open Access

    A Mixed Methods Approach to Explore the Experience of Pain and Its Management in People with Parkinson’s Disease

    by Vanessa Nguy, Bernadette Brady, Leanne M. Hassett, Colleen G. Canning, James M. Elliott, Natalie E. Allen

    Introduction. Pain in Parkinson’s disease (PD) is common but poorly understood, with most research to date taking a mechanistic approach. This mixed methods study takes a broader biopsychosocial approach to assess and describe contributors of pain and explore pain management and the relationship between pain and physical activity in people with PD (PwPD) and chronic pain. Methods. A structured survey evaluated respondents’ contributors of pain using standardized, self-report assessments of the following: pain, peripheral neuropathy, central nociplastic change, emotional dysregulation or pathology, and maladaptive cognitions. Semistructured individual interviews were conducted with purposively sampled survey participants and analyzed using inductive thematic analysis. Results. Eighty-nine PwPD (mean age 67 years, 55% female) completed the survey. The most common pain contributors were maladaptive cognitions (62%), central nociplastic change (49%), and emotional dysregulation (44%). Approaches to pain management and the response to physical activity were variable within and across individuals with different pain contributors. Four themes emerged from interviews with 24 participants: (1) causative perceptions of pain are diverse; (2) sense of control influences disease acceptance and exercise self-efficacy; (3) belief in the value of therapy; and (4) pain as the unspoken PD symptom. Physical activity was used by PwPD for pain management; however, the relationship between pain and physical activity varied based on sense of control. Conclusions. Clinicians should screen for pain and assess its contributors to provide individualized, multidimensional pain management that considers the biological, psychological, and social factors of pain in PwPD. It is plausible that such an approach would promote a better sense of control for PwPD.